Scandinavia and the Baltic States have long enjoyed strong political and economic ties, trading across the Baltic Sea for centuries.

The explosive growth of infringing online pharmacies and weight-loss medication scams is reshaping pharmaceutical enforcement. Following the landmark Novo Nordisk case, the English High Court has granted the first website-blocking order targeting unlicensed medicine sales, marking a significant expansion beyond traditional digital piracy enforcement. This development raises critical questions about the evolving role of regulators, the scope of dynamic blocking orders, and how rights holders can effectively

Circular construction is the practice of reusing and reappropriating buildings and building materials to ensure they are reused, adapted and rebuilt for as long as possible.

As a university student or academic you might be vaguely aware of intellectual property (IP) as a concept but you may still not be entirely clear on why IP is so important...

Two terms frequently used in this context are intellectual property rights and intellectual capital but what is the difference between...

Every type of business needs to get off to the best possible start. For a food & drink business the best possible start will almost always involve investment but how can you use intellectual...

Pharmaceutical companies are exploring microgravity environments to develop improved drug formulations and discover novel crystal forms of medicines. From monoclonal antibody treatments...

The Supreme Administrative Court in the Czech Republic has referred questions to the Court of Justice of the EU (CJEU) about whether a substance categorised as an excipient in a marketing authorisation...

Biochar has rapidly shifted from a niche soil amendment to a key climate technology, with Europe expanding from 20 production plants in 2015 to more than 200 by 2024 as demand...

Harnessing solar energy, our most abundant renewable energy resource, has enormous potential for climate change mitigation.

The UK's medicines regulator is proposing fundamental changes to how gene therapy products are defined, shifting from origin-based classifications to mechanism-driven frameworks. This consultation raises critical questions about where regulatory boundaries will be drawn for synthetic biology, genome editing platforms, and engineered cell therapies as biotechnology advances beyond traditional biological manufacturing.

The UPC's Central Division revoked Harvard's EP 2 794 928 B1 patent, citing lack of novelty and inventive step. It confirmed jurisdiction despite parallel German proceedings, emphasizing procedural efficiency and rejecting late-stage amendments.

However, Ford has been featured on the BESTmag website recently for their new US patent application US 2023/219440 for a "Charging Trailer" for towing behind an electric vehicle.

Recent U.S. lawsuits and EU regulations underscore the importance of transparent labeling in the confectionery industry, highlighting the risks of deceptive health claims that mislead consumers and harm market integrity.

As you're participating in the Food & Bio Summit, you will have a serious interest in the biotechnical aspects of the food and drink industry.

The COVID-19 pandemic thrust mRNA technology into the global spotlight, transforming decades of foundational research into commercially valuable vaccines almost overnight. This rapid commercialization, combined with enormous revenues and a complex web of overlapping patents, has triggered an unprecedented wave of intellectual property disputes that is reshaping how value is allocated across the biotechnology industry and determining who controls access to next-generation RNA-based medicines.

As debt financing increasingly recognizes the value of intangible assets, companies must strategically prepare their intellectual property portfolios to meet lender expectations.

The UK Supreme Court has brought welcome clarity to the patentability of software and AI inventions by adopting the European Patent Office's "any hardware" approach and moving away from the long‑standing Aerotel test.

The implementation of the Windsor Framework on 1 January 2025 marked a significant turning point in the UK's regulatory landscape for human medicines.

Private equity and venture capital investors conduct rigorous due diligence to uncover hidden risks that could derail deals, with many of the biggest threats stemming from intellectual property, legal ownership, and governance issues rather than financial metrics. Understanding these potential deal killers and addressing them proactively can significantly improve a scaling business's chances of securing investment, acquisition offers, or international expansion opportunities.